Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS)

For EOC patients, close monitoring of blood pressure, heart rate, and coagulation function should be conducted when selecting niraparib for treatment.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Safety
Published
2024-08-12
DOI
https://doi.org/10.1080/14740338.2024.2390640
Citations
2
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS)

Chenguang Yang, Hongmei Sun, Chengjiang Liu, Xuan Song et al.
2 citations
Expert Opinion on Drug Safety
PARP inhibition in cancer therapy
0.57
article

Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS)

Chenguang Yang, Hongmei Sun, Chengjiang Liu, Xuan Song, Xi Chen, Min Chen
article en
2 citations

Abstract

For EOC patients, close monitoring of blood pressure, heart rate, and coagulation function should be conducted when selecting niraparib for treatment.

Expert Opinion on Drug SafetyVol. 24(9)
Wannan Medical College (CN), Anhui Medical University (CN), First Affiliated Hospital of Anhui Medical University (CN), First Affiliated Hospital of Wannan Medical College (CN), Zhejiang University (CN)
Good health and well-being
Openalex Percentile: Top 28%
PARP inhibition in cancer therapy
0.57
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS) — Chenguang Yang, Hongmei Sun, et al. · Expert Opinion on Drug Safety (2024) | TGRS Research Map | TGRS